Expertise in
3
conditions

Joren Callaert

AZ Sint Blasius
Dendermonde, VLG, BE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
3
conditions
AZ Sint Blasius
Dendermonde, VLG, BE 

Overview

Joren Callaert practices practicing medicine in Dendermonde, Belgium.

Mr. Callaert is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Peripheral Artery Disease, Atherosclerosis, Cystic Hygroma, Angioplasty, and Stent Placement.

He is actively involved in clinical research, co-authoring 36 peer reviewed articles and participating in 9 clinical trials.

Gender

Male

Locations

AZ Sint Blasius
Dendermonde, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

An RCT Evaluating the Safety and Efficacy of the Endovascular Treatment of Subjects with Stenotic or Restenotic Lesions of the Common Femoral Artery with the Supera Vascular Mimetic Implant Compared to Surgical Common Femoral Artery Endarterectomy
An RCT Evaluating the Safety and Efficacy of the Endovascular Treatment of Subjects with Stenotic or Restenotic Lesions of the Common Femoral Artery with the Supera Vascular Mimetic Implant Compared to Surgical Common Femoral Artery Endarterectomy
Enrollment Status: Recruiting
Publish Date: October 16, 2024
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Belgian Physician-initiated Trial Investigating the LifeStream Peripheral Stent Graft System for the Treatment of Complex TASC C and D Iliac Lesions
Belgian Physician-initiated Trial Investigating the LifeStream Peripheral Stent Graft System for the Treatment of Complex TASC C and D Iliac Lesions
Enrollment Status: Completed
Publish Date: March 05, 2026
Intervention Type: Device
Study Phase: Not Applicable
Physician Initiated, Prospective, Non-randomized Belgian Multi-center Trial, Investigating the Safety and Efficacy of the Treatment With the LumINor DCB and The IvolutioN Stent of iVascular in TASC C and D Femoropopliteal Atherosclerotic Disease
Physician Initiated, Prospective, Non-randomized Belgian Multi-center Trial, Investigating the Safety and Efficacy of the Treatment With the LumINor DCB and The IvolutioN Stent of iVascular in TASC C and D Femoropopliteal Atherosclerotic Disease
Enrollment Status: Completed
Publish Date: March 06, 2025
Intervention Type: Device
Study Phase: Not Applicable
Belgian-Italian Prospective, Single Arm, Multicentre Study to Evaluate the Efficacy and Safety of BTK Treatment With the Luminor 14 Paclitaxel Coated Percutaneous Transluminal Angioplasty Balloon Catheter of iVascular of 150 Subjects With Critical Limb Ischemia
Belgian-Italian Prospective, Single Arm, Multicentre Study to Evaluate the Efficacy and Safety of BTK Treatment With the Luminor 14 Paclitaxel Coated Percutaneous Transluminal Angioplasty Balloon Catheter of iVascular of 150 Subjects With Critical Limb Ischemia
Enrollment Status: Completed
Publish Date: November 08, 2024
Intervention Type: Device
Study Phase: Not Applicable
Belgian Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Evaluation of the Safety and Efficacy of the ClearLumen II Peripheral Thrombectomy System Recanalization of Acute and Subacute Thrombotic Femoropopliteal Occlusions
Belgian Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Evaluation of the Safety and Efficacy of the ClearLumen II Peripheral Thrombectomy System Recanalization of Acute and Subacute Thrombotic Femoropopliteal Occlusions
Enrollment Status: Completed
Publish Date: October 16, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Controlled Non-inferiority Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of Subjects with Stenotic, Restenotic or Occlusive Lesions of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon
A Randomized Controlled Non-inferiority Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of Subjects with Stenotic, Restenotic or Occlusive Lesions of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon
Enrollment Status: Active_not_recruiting
Publish Date: October 16, 2024
Intervention Type: Device
Study Phase: Not Applicable
Prospective, Multi-center, Non-Randomized Controlled Trial of Vascular Closure Using the AbsorbaSeal 6 French Vascular Closure Device
Prospective, Multi-center, Non-Randomized Controlled Trial of Vascular Closure Using the AbsorbaSeal 6 French Vascular Closure Device
Enrollment Status: Terminated
Publish Date: September 08, 2021
Intervention Type: Device
Study Phase: Not Applicable
Prospective, Multicenter, Single Arm, Pre-CE Marked Study of the AbsorbaSeal (ABS 5.6.7) Vascular Closure Device
Prospective, Multicenter, Single Arm, Pre-CE Marked Study of the AbsorbaSeal (ABS 5.6.7) Vascular Closure Device
Enrollment Status: Completed
Publish Date: September 05, 2021
Intervention Type: Device
Study Phase: Not Applicable
EVOLUTION STUDY, a Physician-inititated Trial Investigating the Efficacy of the Self-Expanding iVolution Nitinol Stent for Treatment of Femoropopliteal Lesions
EVOLUTION STUDY, a Physician-inititated Trial Investigating the Efficacy of the Self-Expanding iVolution Nitinol Stent for Treatment of Femoropopliteal Lesions
Enrollment Status: Completed
Publish Date: August 13, 2018
Intervention Type: Device
Study Phase: Phase 2/Phase 3
View 8 Less Clinical Trials

36 Total Publications

Endovascular Management of the Sutton-Kadir Syndrome: A Case Report.
Endovascular Management of the Sutton-Kadir Syndrome: A Case Report.
Journal: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
Published: March 30, 2026

Frequently Asked Questions about Joren Callaert

Is Joren Callaert a top-rated expert for Peripheral Artery Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Joren Callaert is classified as an Distinguished expert for Peripheral Artery Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Joren Callaert participate in research or clinical trials?

Yes. Joren Callaert has published 36 articles and abstracts on conditions like Peripheral Artery Disease. You can view a list of Joren Callaert's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Callaert's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile